Answers are grounded in this paper and cite their sources.
Summary“Inderal” (Ayerst 64043, Imperial Chemical Industries 45,520, proprano-lol) an adrenergic beta receptor antagonist, acts synergistically with insulin in the rat to induce a hypoglycemia much more severe than that resulting from insulin alone. This synergism may possibly be of clinical significance.
No takes yet. Share an insight, caveat, or question.
Byeks et al. (1966) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: